Best TWAS P=1.61e-30 · Best GWAS P=2.06e-53 conditioned to 1.2e-31
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | RP11-446E9.1 | 0.07 | 0.00 | lasso | 6 | 0.00 | 6.6e-01 | -7.0 | 8.3 | 7.2e-17 | -0.71 | 0.03 | 0.63 | FALSE |
2 | GTEx | Brain Cerebellum | RPS20 | 0.26 | 0.07 | enet | 17 | 0.10 | 5.4e-04 | -10.1 | -8.8 | 1.0e-18 | 0.64 | 0.13 | 0.67 | FALSE |
3 | GTEx | Brain Cerebellum | RP11-446E9.1 | 0.15 | 0.05 | lasso | 3 | 0.03 | 3.7e-02 | -6.7 | 6.5 | 8.7e-11 | -0.54 | 0.06 | 0.47 | FALSE |
4 | GTEx | Brain Nucleus accumbens basal ganglia | RPS20 | 0.41 | 0.05 | lasso | 8 | 0.13 | 3.1e-04 | -7.3 | -6.8 | 8.8e-12 | 0.54 | 0.04 | 0.41 | FALSE |
5 | GTEx | Cells EBV-transformed lymphocytes | LYN | 0.35 | 0.07 | enet | 37 | 0.17 | 4.5e-06 | 11.0 | -5.4 | 6.9e-08 | -0.12 | 0.15 | 0.05 | TRUE |
6 | GTEx | Esophagus Muscularis | RPS20 | 0.12 | 0.04 | lasso | 6 | 0.05 | 7.2e-04 | -10.2 | -9.9 | 3.1e-23 | 0.81 | 0.20 | 0.68 | FALSE |
7 | GTEx | Muscle Skeletal | RPS20 | 0.07 | 0.09 | lasso | 1 | 0.07 | 1.5e-07 | -6.6 | -6.6 | 5.0e-11 | 0.52 | 0.92 | 0.08 | FALSE |
8 | GTEx | Skin Not Sun Exposed Suprapubic | RPS20 | 0.18 | 0.03 | enet | 12 | 0.07 | 1.5e-04 | -9.7 | -11.5 | 1.6e-30 | 0.80 | 0.15 | 0.46 | TRUE |
9 | GTEx | Stomach | RP11-446E9.1 | 0.12 | 0.08 | lasso | 4 | 0.03 | 1.7e-02 | -6.1 | 6.0 | 1.7e-09 | -0.51 | 0.26 | 0.20 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | RPS20 | 0.24 | 0.20 | lasso | 6 | 0.23 | 3.4e-29 | -8.3 | -7.3 | 2.2e-13 | 0.55 | 1.00 | 0.00 | FALSE |
11 | ROSMAP | Brain Pre-frontal Cortex | RP11-446E9.1 | 0.23 | 0.32 | lasso | 7 | 0.34 | 2.0e-45 | -6.6 | 7.6 | 3.5e-14 | -0.56 | 1.00 | 0.00 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | PENK | 0.03 | 0.01 | blup | 40 | 0.03 | 9.1e-04 | -4.8 | -5.3 | 1.4e-07 | 0.00 | 0.02 | 0.68 | FALSE |
13 | The Cancer Genome Atlas | Colon Adenocarcinoma | PENK | 0.11 | 0.13 | lasso | 2 | 0.14 | 2.6e-08 | -5.1 | -5.3 | 1.4e-07 | 0.02 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | PENK | 0.07 | 0.06 | enet | 8 | 0.08 | 2.4e-09 | -4.6 | -5.3 | 1.2e-07 | 0.03 | 0.02 | 0.97 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | RPS20 | 0.04 | 0.02 | blup | 29 | 0.03 | 4.8e-04 | -8.1 | -7.4 | 1.3e-13 | 0.51 | 0.03 | 0.03 | FALSE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | RPS20 | 0.33 | 0.07 | enet | 8 | 0.07 | 1.7e-08 | -8.3 | -9.5 | 1.4e-21 | 0.52 | 0.96 | 0.03 | FALSE |
17 | The Cancer Genome Atlas | Prostate Adenocarcinoma | RPS20 | 0.04 | 0.03 | lasso | 3 | 0.04 | 1.3e-04 | -8.3 | -8.3 | 8.5e-17 | 0.60 | 0.15 | 0.05 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | LYN | 0.09 | 0.12 | lasso | 2 | 0.12 | 8.4e-12 | -6.1 | 6.2 | 6.7e-10 | -0.53 | 1.00 | 0.00 | FALSE |